RSMD.F Stock Overview
Develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
ResMed Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$17.70 |
| 52 Week High | US$19.17 |
| 52 Week Low | US$13.72 |
| Beta | 0.66 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | -19.58% |
| 33 Year Change | -23.87% |
| 5 Year Change | 59.46% |
| Change since IPO | 547.78% |
Recent News & Updates
Recent updates
Shareholder Returns
| RSMD.F | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0% | -0.3% | 1.9% |
| 1Y | -19.6% | 21.7% | 32.8% |
Return vs Industry: RSMD.F underperformed the US Medical Equipment industry which returned -1.9% over the past year.
Return vs Market: RSMD.F underperformed the US Market which returned 22% over the past year.
Price Volatility
| RSMD.F volatility | |
|---|---|
| RSMD.F Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 8.7% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 14.9% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: RSMD.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine RSMD.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 10,140 | Mick Farrell | www.resmed.com |
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. It operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes.
ResMed Inc. Fundamentals Summary
| RSMD.F fundamental statistics | |
|---|---|
| Market cap | US$30.09b |
| Earnings (TTM) | US$958.38m |
| Revenue (TTM) | US$4.58b |
31.4x
P/E Ratio6.6x
P/S RatioIs RSMD.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RSMD.F income statement (TTM) | |
|---|---|
| Revenue | US$4.58b |
| Cost of Revenue | US$1.99b |
| Gross Profit | US$2.59b |
| Other Expenses | US$1.63b |
| Earnings | US$958.38m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 01, 2024
| Earnings per share (EPS) | 6.52 |
| Gross Margin | 56.51% |
| Net Profit Margin | 20.91% |
| Debt/Equity Ratio | 21.7% |
How did RSMD.F perform over the long term?
See historical performance and comparison